Indivior PLC announced the appointment of four new Non-Executive Directors (the "new NEDs") to its Board of Directors (the "Board") as well as details of a comprehensive and phased Board succession plan. These important governance changes are designed to fully align and support Indivior's Strategic Priorities while continuing to represent the best interests of all shareholders. This process had commenced with the departure or coming departure of three Board members. The company also announces that following a period of constructive dialogue, it has entered into a relationship agreement (the "Relationship Agreement") with its large shareholder, Scopia Capital Management LP ("Scopia"), that will see Indivior benefit from Scopia's insight and perspectives as an experienced healthcare investor. The appointment of three new independent NEDs: Juliet Thompson, Joanna "Jo" Le Couilliard, and Mark Stejbach; The appointment of Jerome Lande, a Partner of Scopia, as a new NED; and The intention to appoint an additional new independent NED from a shortlist to be generated with Scopia's input and approved by the Board.